Bioqual (BIOQ)
(Delayed Data from OTC)
$67.50 USD
0.00 (0.00%)
Updated Sep 19, 2024 02:35 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Bioqual Inc falls in the month of May.
All items in Millions except Per Share data.
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 7 | 2 | 8 | 10 |
Receivables | NA | 23 | 27 | 20 | 15 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 0 | 3 | 1 | 1 |
Total Current Assets | NA | 30 | 32 | 29 | 26 |
Net Property & Equipment | NA | 13 | 13 | 10 | 7 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 1 | 1 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 1 |
Total Assets | NA | 61 | 63 | 53 | 17 |
Liabilities & Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 2 | 2 | 2 | 2 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 1 | 1 | 1 |
Total Current Liabilities | NA | 8 | 10 | 9 | 8 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 24 | 26 | 20 | 21 |
Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 7 | 7 | 7 | 7 |
Retained Earnings | NA | 31 | 31 | 27 | 22 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 1 | 1 | 1 | 1 |
Total Shareholder's Equity | NA | 38 | 38 | 34 | 28 |
Total Liabilities & Shareholder's Equity | NA | 61 | 63 | 53 | 50 |
Total Common Equity | 0 | 38 | 38 | 34 | 28 |
Shares Outstanding | NA | NA | 0.90 | 0.90 | 0.80 |
Book Value Per Share | 0.00 | 0.00 | 41.86 | 37.26 | 35.23 |
Fiscal Year End for Bioqual Inc falls in the month of May.
All items in Millions except Per Share data.
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 12 | 10 | 6 |
Receivables | NA | NA | 18 | 19 | 22 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 0 | 0 | 0 |
Other Current Assets | NA | NA | 1 | 2 | 3 |
Total Current Assets | NA | NA | 32 | 31 | 32 |
Net Property & Equipment | NA | NA | 11 | 12 | 12 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 1 | 1 | 1 |
Deposits & Other Assets | NA | NA | 0 | 0 | 0 |
Total Assets | NA | NA | 59 | 59 | 61 |
Liabilities & Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | 0 |
Accounts Payable | NA | NA | 1 | 2 | 3 |
Current Portion Long-Term Debt | NA | NA | 0 | 0 | 0 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | NA | 2 | 2 | 1 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 1 | 0 | 1 |
Total Current Liabilities | NA | NA | 8 | 7 | 8 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 0 | 0 | 0 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 0 | 0 | 0 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 20 | 21 | 23 |
Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 0 | 0 | 0 |
Capital Surplus | NA | NA | 7 | 7 | 7 |
Retained Earnings | NA | NA | 32 | 32 | 32 |
Other Equity | NA | NA | 0 | 0 | 0 |
Treasury Stock | NA | NA | 1 | 1 | 1 |
Total Shareholder's Equity | NA | NA | 39 | 39 | 39 |
Total Liabilities & Shareholder's Equity | NA | NA | 59 | 59 | 61 |
Total Common Equity | 0 | 0 | 39 | 39 | 39 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |